80/100BZOETIS stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for ZOETIS is 84.75, 2.3% above the current price of 82.86. Their targets range from 74.00 to 95.00.
Of the 15 firms that rated ZOETIS in the past 12 months, 7 rate it buy or strong buy, 8 hold and 0 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 74.00 to 95.00, with an average of 84.75.
| Buy | 7 | |
| Hold | 8 | |
| Sell | 0 |
12-month price target
| Highest target | 95.00 |
| Average target | 84.75 |
| Lowest target | 74.00 |
| Current price | 82.86 |
ZOETIS price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their ZOETIS price target and rating?
How analysts rate ZOETIS, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
7 of 15 firms rate it buy now, against 6 of 9 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
ZOETIS analyst upgrades, downgrades and price targets
The latest rating change came on 20 October 2026, when Jefferies downgraded ZOETIS from Buy to Hold. Its price target is 83.00. The most recent new target came from Morgan Stanley on 29 October 2026: 82.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 29 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 85.00 → 82.00 | -3.5% | 77.86 |
| 20 Oct 2026 | Jefferies Keith Devas | Downgraded · Buy → Hold | 83.00 | — | 79.59 |
| 16 Oct 2026 | Goldman Sachs | — | 74.00 | — | 78.42 |
| 25 Aug 2026 | Cantor Fitzgerald | — | 94.00 | — | 77.17 |
| 20 Aug 2026 | Stifel Nicolaus Jonathan Block | Reiterated · Hold | 85.00 → 80.00 | -5.9% | 76.68 |
| 7 Aug 2026 | Morgan Stanley | — | 99.00 → 85.00 | -14.1% | 75.30 |
| 6 Aug 2026 | William Blair | Downgraded · Outperform → Market Perform | — | — | — |
| 27 Jul 2026 | UBS | Reiterated · Neutral | 99.00 → 85.00 | -14.1% | 76.52 |
| 22 Jul 2026 | Morgan Stanley | Reiterated · Overweight | 115.00 → 99.00 | -13.9% | 75.50 |
| 6 Jul 2026 | HSBC | Reiterated · Buy | 140.00 → 95.00 | -32.1% | 74.63 |
| 1 Jul 2026 | Barclays | Reiterated · Equal Weight | 136.00 → 85.00 | -37.5% | 71.91 |
| 26 Jun 2026 | Stifel Nicolaus | Reiterated · Hold | 95.00 → 85.00 | -10.5% | 77.82 |
| 27 May 2026 | Argus Research | Downgraded · Buy → Hold | — | — | — |
| 22 May 2026 | Stifel Nicolaus | Reiterated · Hold | 105.00 → 95.00 | -9.5% | 80.06 |
| 15 May 2026 | Morgan Stanley Erin Wright | — | 160.00 → 115.00 | -28.1% | 76.06 |
| 8 May 2026 | UBS | Reiterated · Neutral | 130.00 → 99.00 | -23.8% | 83.27 |
| 8 May 2026 | Stifel Nicolaus | — | 140.00 → 105.00 | -25.0% | 87.31 |
| 28 Apr 2026 | UBS | Reiterated · Neutral | 136.00 → 130.00 | -4.4% | 116.71 |
| 26 Feb 2026 | BTIG Mark Massaro | — | 160.00 | — | 128.95 |
| 29 Jan 2026 | UBS | — | 158.00 → 136.00 | -13.9% | 122.75 |
| 22 Jan 2026 | Piper Sandler David Westenberg | Downgraded · Overweight → Neutral | 215.00 → 135.00 | -37.2% | 125.08 |
| 18 Dec 2025 | Morgan Stanley | — | 243.00 → 160.00 | -34.2% | 124.54 |
| 10 Dec 2025 | HSBC | — | 140.00 | — | 115.75 |
| 8 Dec 2025 | Barclays | — | 136.00 | — | 118.16 |
ZOETIS EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect ZOETIS's EPS to grow 3.8% a year until 2028, slower than over the last 5 years (12.0% a year) and the last 3 years (10.3%).
Analysts expect ZOETIS's revenue to grow 0.5% a year until 2028, slower than over the last 5 years (7.2% a year) and the last 3 years (5.4%).
Revenue
EPS
Does ZOETIS beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 5.8% off the result, either way, and their revenue estimate 1.8%, over the last 12 quarters.
- EPS beats
- 46 / 56
- Revenue beats
- 45 / 55
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +4.1%
- Since
- March 2013
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | 1.51 | 1.75 | +15.9% | 2.30B | 2.39B | +3.8% |
| Q2 FY2026 | 6 Aug 2026 | 1.85 | 1.87 | +1.1% | 2.50B | 2.47B | -1.3% |
| Q1 FY2026 | 7 May 2026 | 1.60 | 1.53 | -4.4% | 2.30B | 2.26B | -1.7% |
| Q4 FY2025 | 12 Feb 2026 | 1.40 | 1.48 | +5.7% | 2.36B | 2.39B | +1.1% |
| Q3 FY2025 | 4 Nov 2025 | 1.62 | 1.70 | +4.9% | 2.41B | 2.40B | -0.4% |
| Q2 FY2025 | 5 Aug 2025 | 1.62 | 1.76 | +8.6% | 2.41B | 2.46B | +2.1% |
| Q1 FY2025 | 6 May 2025 | 1.41 | 1.48 | +5.0% | 2.19B | 2.22B | +1.4% |
| Q4 FY2024 | 13 Feb 2025 | 1.37 | 1.40 | +2.2% | 2.30B | 2.32B | +0.9% |
| Q3 FY2024 | 4 Nov 2024 | 1.46 | 1.58 | +8.2% | 2.29B | 2.39B | +4.3% |
| Q2 FY2024 | 6 Aug 2024 | 1.49 | 1.56 | +4.7% | 2.31B | 2.36B | +2.1% |
| Q1 FY2024 | 2 May 2024 | 1.34 | 1.38 | +3.0% | 2.15B | 2.19B | +1.7% |
| Q4 FY2023 | 13 Feb 2024 | 1.32 | 1.24 | -6.1% | 2.19B | 2.21B | +1.1% |
ZOETIS stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If ZOETIS's earnings keep growing at the 1.6% a year analysts expect to FY2028, it would earn about 6.94 a share in FY2030. At the P/E it has traded at over the last five years (14.1 to 56.9) that is 97.60 to 394.63 a share, or 223.10 at its average P/E of 32.2. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 6.31 | 88.76 | 202.90 | 358.90 |
| FY2027 | 6.31 | 88.76 | 202.89 | 358.89 |
| FY2028 | 6.73 | 94.62 | 216.29 | 382.58 |
| FY2029 (extrapolated) | 6.83 | 96.09 | 219.67 | 388.56 |
| FY2030 (extrapolated) | 6.94 | 97.60 | 223.10 | 394.63 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 1.6% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (14.1, 32.2, 56.9).
Is ZOETIS stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
ZOETIS's P/E of 14.1 is near the bottom of its 5-year range (11.4 to 59.3, median 33.7). Analysts expect slower growth than in recent years, so the low P/E may be deserved. Buyers pay more for each point of growth than usual: a PEG of 3.7 on expected growth against 2.8 on its median P/E and past five years' growth. Fair value is not a reliable guide for ZOETIS: its usual P/E would put it at 198.77, 58.3% from the price, too far for its P/E history to be a fair guide. Its forward P/E, on the consensus for FY2026, is 13.1.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 14.07
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 33.75
- Five-year P/E range
- 11.4 – 59.3
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 13.13
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 9.00
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +2.3%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.